A better understanding of BCL-XL, and more in general of BCL-2 family members, will provide an insight into the molecular mechanism of tumor progression, how conventional chemotherapy selectively kills cancer cells, and why some cancers are more chemosensitive than others. This evidence concerns the gene BCL2 and neoplasm.